Bicycle Therapeutics plc American Depositary Shares (BCYC)
Stock · NASDAQ · Health Care
$3.45as of 10/16/2026
Price chart
Active signals
BCYC Signal Track Record
How signals performed across all stocks →What BCYC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 38 | -5.6% | 39% | September 24, 2026 |
| Bollinger Band Breakdown | 21 | +4.2% | 57% | September 15, 2026 |
| Bollinger Band Breakout | 21 | -5.7% | 33% | August 20, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -1.1% | 50% | October 30, 2025 |
| Any 20-session window (baseline) | -4.4% | 39% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About BCYC
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 288
- Website
- www.bicycletherapeutics.com/
Fundamentals
- 1-day range
- $3.42$3.6
- Market cap
- $277.87M
- P/E (trailing)
- —
- P/E (forward)
- -1.56
- EPS (trailing)
- $-2.74
- Dividend yield
- —
- Beta
- 1.62
- Avg. volume
- 392.3K
How Bicycle Therapeutics plc American Depositary Shares Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 17, 2026 · via SEC EDGAR / Finnhub
Forecasts
6 analyst ratings
Bicycle Therapeutics plc American Depositary Shares Competitors
Chosen by industry and closest market cap.
- BCYCBicycle Therapeutics plc American Depositary Shares$3.46▼ 3.89%Market cap $277.87MP/E —$3.33$9.08
- EBSEmergent BioSolutions Inc. Common Stock$6.38▼ 11.14%Market cap $273.98MP/E —$4.36$14.06
- CAMPCAMP4 Therapeutics Corporation Common Stock$3.17▼ 8.12%Market cap $282.25MP/E —$2.86$7.75
- ADAGAdagene Inc. American Depositary Shares$2.06▼ 14.17%Market cap $273.45MP/E —$1.3$4.85
- ALXOALX Oncology Holdings Inc. Common Stock$1.06▲ 6.00%Market cap $283.93MP/E —$0.8617$2.66
- CLLSCellectis S.A. American Depositary Shares$1.04▼ 5.88%Market cap $270.42MP/E —$1.04$4.75
- TTRXTurn Therapeutics Inc. Common Stock$10.57▼ 8.80%Market cap $286.26MP/E —$2.57$26.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BCYC Bicycle Therapeutics plc American Depositary Shares | $277.87M | — | $3.46 | ▼ 3.89% | $3.33$9.08 |
| EBS Emergent BioSolutions Inc. Common Stock | $273.98M | — | $6.38 | ▼ 11.14% | $4.36$14.06 |
| CAMP CAMP4 Therapeutics Corporation Common Stock | $282.25M | — | $3.17 | ▼ 8.12% | $2.86$7.75 |
| ADAG Adagene Inc. American Depositary Shares | $273.45M | — | $2.06 | ▼ 14.17% | $1.3$4.85 |
| ALXO ALX Oncology Holdings Inc. Common Stock | $283.93M | — | $1.06 | ▲ 6.00% | $0.8617$2.66 |
| CLLS Cellectis S.A. American Depositary Shares | $270.42M | — | $1.04 | ▼ 5.88% | $1.04$4.75 |
| TTRX Turn Therapeutics Inc. Common Stock | $286.26M | — | $10.57 | ▼ 8.80% | $2.57$26.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Jennifer Scott Perry · October 5, 2026 · Sale326 @ $3.78
- Jennifer Scott Perry · October 5, 2026 · Sale30 @ $3.57
- Jennifer Scott Perry · October 5, 2026 · Sale80 @ $3.56
- Michael Charles Ferguson Hannay · October 5, 2026 · Sale242 @ $3.57
- Travis Alvin Thompson · October 5, 2026 · Sale79 @ $3.57
- Kevin Lee · October 5, 2026 · Sale1.6K @ $3.57
- Michael Skynner · October 5, 2026 · Sale503 @ $3.57
- Jennifer Scott Perry · October 2, 2026 · Sale1.1K @ $3.47
- Robert Charles Swanton · October 2, 2026 · Sale3.4K @ $3.47
- Michael Charles Ferguson Hannay · October 2, 2026 · Sale1.6K @ $3.47
- Travis Alvin Thompson · October 2, 2026 · Sale893 @ $3.47
- Kevin Lee · October 2, 2026 · Sale6.2K @ $3.47
- Michael Skynner · October 2, 2026 · Sale1.9K @ $3.47
- Michael Charles Ferguson Hannay · July 15, 2026 · Grant60.0K
- Travis Alvin Thompson · July 15, 2026 · Grant60.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 37.83M
- Total value held
- $161.05M
- Institutional holders
- 96
- Unknown10.89M
- Unknown3.47M
- Unknown3.40M
- Unknown3.31M
- Unknown1.97M
- Unknown1.56M
- Unknown1.53M
- Unknown1.17M
- Unknown1.03M
- Unknown979.3K
See the full, filterable feed with live charts on the MarketWall dashboard.